Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-16T18:45:13.187Z Has data issue: false hasContentIssue false

Gender differences in Generalized Anxiety Disorder: a cross-sectional multicenter study

Published online by Cambridge University Press:  31 July 2026

M. Buoli*
Affiliation:
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan
L. M. Affaticati
Affiliation:
University of Milan Bicocca
E. Capuzzi
Affiliation:
Fondazione IRCCS San Gerardo dei Tintori, Monza
F. Colmegna
Affiliation:
ASST Bergamo Ovest, Bergamo
M. Clerici
Affiliation:
University of Milan Bicocca, Milan, Italy
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Introduction

Generalized Anxiety Disorder (MDD) is a disabling mental condition, with a prevalence in women twice than men. Despite the implementation of precision and gender medicine, little data are currently available on gender differences in GAD.

Objectives

Purpose of this study is to identify gender differences in clinical features and outcomes of patients affected by GAD to implement individualized treatment strategies.

Methods

A cross-sectional, retrospective study was conducted. Medical records of GAD patients from three mental health services were reviewed, and socio-demographic and clinical variables were extracted. Continuous and qualitative variables were compared according to gender respectively by unpaired t-tests and chi-square tests (with odds ratio-[OR] calculation where appropriate).

Results

The total sample included 243 patients (162 women and 81 men). Female patients compared to males resulted: to be more frequently married or in partnership (61.7% versus 44.4%; χ2=8.68, p=0.03), to have less frequently cannabis use disorder before GAD onset (0.6% versus 7.4%; χ2=13.71, p=0.01), to have less frequently alcohol use disorder after GAD onset (0.6% versus 6.2%; χ2=13.68, p<0.01), to have more frequently committed attempted suicides (4.9% versus 0.0%; χ2=4.14, p=0.05), to present more often a history of obstetrical complications (low birth weight or preterm birth) (5.5% versus 0.0%; χ2=4.14, p=0.03; OR=1.54).

Conclusions

The results of this study support gender-specific medicine with personalized treatments for males and females with GAD. Males are more likely to engage in substance abuse, while females are more likely to engage in self-harm. Specific psychoeducational interventions should be planned, and pharmacotherapy should be chosen based on their interactions with substances of abuse or their anti-suicidal efficacy. The results of this study need to be confirmed by future research.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.